These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19064545)

  • 1. Triple-negative breast cancer and obesity in a rural Appalachian population.
    Vona-Davis L; Rose DP; Hazard H; Howard-McNatt M; Adkins F; Partin J; Hobbs G
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3319-24. PubMed ID: 19064545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and demographic evaluation of triple- negative breast cancer patients among a turkish patient population: a single center experience.
    Somali I; Ustaoglu BY; Tarhan MO; Yigit SC; Demir L; Ellidokuz H; Erten C; Alacacioglu A
    Asian Pac J Cancer Prev; 2013; 14(10):6013-7. PubMed ID: 24289617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].
    Guan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):196-9. PubMed ID: 18756935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological features of breast cancer in Jordan: Experience from a tertiary care hospital.
    Obeidat F; Ahram M; Al Khader A; Battah K; Alchalabi M; Melhem JM; Suleiman A
    J Pak Med Assoc; 2017 Aug; 67(8):1206-1212. PubMed ID: 28839305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.
    Alarcón Rojas CA; Alvarez-Bañuelos MT; Morales-Romero J; Suárez-Díaz H; Hernández-Fonseca JC; Contreras-Alarcón G
    Clin Breast Cancer; 2019 Feb; 19(1):e166-e171. PubMed ID: 30236925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-negative breast cancer in West Virginia.
    Abraham J; Flanagan M; Hazard H; Jubelirer S; Tirona MT; Vona-Davis L
    W V Med J; 2009 Oct; 105 Spec No():54-9. PubMed ID: 19999267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.
    Gaudet MM; Press MF; Haile RW; Lynch CF; Glaser SL; Schildkraut J; Gammon MD; Douglas Thompson W; Bernstein JL
    Breast Cancer Res Treat; 2011 Nov; 130(2):587-97. PubMed ID: 21667121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
    Kim BS; Sung SH
    Ann Nucl Med; 2012 Feb; 26(2):175-83. PubMed ID: 22139552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?
    Raica M; Cîmpean AM; Ceausu RA; Fulga V; Nica C; Rudico L; Saptefrati L
    Anticancer Res; 2014 Mar; 34(3):1435-40. PubMed ID: 24596391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
    Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
    Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement.
    Sofi GN; Sofi JN; Nadeem R; Shiekh RY; Khan FA; Sofi AA; Bhat HA; Bhat RA
    Asian Pac J Cancer Prev; 2012; 13(10):5047-52. PubMed ID: 23244108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.
    Ambroise M; Ghosh M; Mallikarjuna VS; Kurian A
    Asian Pac J Cancer Prev; 2011; 12(3):625-9. PubMed ID: 21627355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
    Majid S; Rydén L; Manjer J
    World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].
    Wang YJ; Wang N; Wang B; Qin WX; Xue CY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):346-50. PubMed ID: 19799082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.